Halozyme Therapeutics, Inc.

BMV:HALO * Stock Report

Market Cap: Mex$88.8b

Halozyme Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BMV:HALO * Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
14 Aug 24SellMex$31,808,894Matthew PosardIndividual29,881Mex$1,086.47
12 Jun 24SellMex$18,902,037Matthew PosardIndividual20,000Mex$950.81

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of HALO *?
Owner TypeNumber of SharesOwnership Percentage
Private Companies13,7670.0104%
Individual Insiders1,242,4620.941%
General Public5,946,9854.5%
Institutions124,894,89694.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 66.23% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.7%
BlackRock, Inc.
18,118,615Mex$12.2b-2.61%0.01%
9.92%
The Vanguard Group, Inc.
13,106,644Mex$8.8b-0.23%0.01%
5.84%
Artisan Partners Limited Partnership
7,712,874Mex$5.2b3.4%0.26%
4.7%
State Street Global Advisors, Inc.
6,209,531Mex$4.2b-4.53%0.01%
3.27%
Snyder Capital Management, L.P.
4,324,232Mex$2.9b0.02%3.54%
2.61%
Macquarie Investment Management Business Trust
3,444,190Mex$2.3b4.07%0.15%
2.54%
AllianceBernstein L.P.
3,356,776Mex$2.3b308%0.04%
2.27%
JP Morgan Asset Management
2,994,186Mex$2.0b-9.32%0.02%
2.11%
Geode Capital Management, LLC
2,787,349Mex$1.9b2.09%0.01%
2.06%
Marshall Wace LLP
2,724,811Mex$1.8b17.3%0.25%
1.77%
GW&K Investment Management, LLC
2,344,305Mex$1.6b-1.48%0.82%
1.52%
Thrivent Investment Management Inc.
2,014,233Mex$1.4b-3.11%0.16%
1.52%
Northern Trust Global Investments
2,008,156Mex$1.3b-0.74%0.01%
1.33%
Invesco Ltd.
1,755,386Mex$1.2b-2.52%0.02%
1.29%
Charles Schwab Investment Management, Inc.
1,698,359Mex$1.1b0.95%0.01%
1.19%
T. Rowe Price Group, Inc.
1,567,911Mex$1.1b-3.8%0.01%
1.16%
ArrowMark Colorado Holdings, LLC
1,527,713Mex$1.0b15.5%0.68%
1.11%
Dimensional Fund Advisors LP
1,467,234Mex$986.3m6.43%0.01%
1.1%
Stephens Investment Management Group, LLC
1,454,707Mex$977.8m8.63%0.84%
1.07%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
1,411,082Mex$948.5m10.3%0.01%
1.02%
Goldman Sachs Asset Management, L.P.
1,346,482Mex$905.1m27.7%0.02%
0.98%
BNY Mellon Asset Management
1,294,400Mex$870.1m-1.25%0.01%
0.73%
New York State Common Retirement Fund
969,999Mex$652.0m2.17%0.05%
0.72%
Norges Bank Investment Management
948,171Mex$637.4m0%no data
0.68%
Millennium Management LLC
901,445Mex$605.9m-50.2%0.03%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/12/20 00:22
End of Day Share Price 2023/09/22 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Halozyme Therapeutics, Inc. is covered by 34 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ishan MajumdarBaptista Research
James BirchenoughBarclays
Robert WassermanBenchmark Company